Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
KAIST brings microbial cell factories one step closer
$18m investment in malaria, TB and NTD projects
Anticancer “nanoswitch” technology developed
Epigenetic mapping provides deeper insight into leukaemia
Base to Base biotech podcast 67: Synthetic DNA and crossing the blood-brain barrier
New CRISPR method makes it possible to control protein production in cells
KAIST enables DNA synthesis using only temperature
Novartis to acquire Myricx Bio